These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 8313413)
1. Drugs which modulate nitric oxide homeostasis are likely to provide therapeutic benefit in cardiovascular disease. Thiemermann C Cardiovasc Res; 1993 Dec; 27(12):2104. PubMed ID: 8313413 [No Abstract] [Full Text] [Related]
2. Drugs which alter nitric oxide homeostasis are unlikely to provide therapeutic benefit in cardiovascular disease. Lefroy DC Cardiovasc Res; 1993 Dec; 27(12):2105. PubMed ID: 8313414 [No Abstract] [Full Text] [Related]
3. Inhibition of NO synthesis in septic shock. Hotchkiss RS; Karl IE; Parker JL; Adams HR Lancet; 1992 Feb; 339(8790):434-5. PubMed ID: 1346700 [No Abstract] [Full Text] [Related]
4. NO inhibitors and septic shock. Cohen J; Silva A Lancet; 1992 Mar; 339(8795):751. PubMed ID: 1347627 [No Abstract] [Full Text] [Related]
5. [Nitric oxide and sepsis]. Gómez Jiménez J; Salgado Remigio A Med Clin (Barc); 1993 Dec; 101(19):741-2. PubMed ID: 7507194 [No Abstract] [Full Text] [Related]
6. Nitric oxide in the clinical arena. Lancet; 1991 Dec 21-28; 338(8782-8783):1560-2. PubMed ID: 1683976 [No Abstract] [Full Text] [Related]
7. Nitric oxide mediates the vascular actions of cytokines in septic shock. Smith RE; Radomski MW; Moncada S Eur J Clin Invest; 1992 Jun; 22(6):438-9. PubMed ID: 1378789 [No Abstract] [Full Text] [Related]
8. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Petros A; Lamb G; Leone A; Moncada S; Bennett D; Vallance P Cardiovasc Res; 1994 Jan; 28(1):34-9. PubMed ID: 7509259 [TBL] [Abstract][Full Text] [Related]
9. Nitric oxide as a target for therapy in septic shock. Cobb JP; Cunnion RE; Danner RL Crit Care Med; 1993 Sep; 21(9):1261-3. PubMed ID: 8370286 [No Abstract] [Full Text] [Related]
11. Use of nitric oxide synthase inhibitors as a novel treatment for septic shock. Wolfe TA; Dasta JF Ann Pharmacother; 1995 Jan; 29(1):36-46. PubMed ID: 7536056 [TBL] [Abstract][Full Text] [Related]
12. NG-methyl-L-arginine, an inhibitor of nitric oxide formation, acts synergistically with dobutamine to improve cardiovascular performance in endotoxemic dogs. Kilbourn RG; Cromeens DM; Chelly FD; Griffith OW Crit Care Med; 1994 Nov; 22(11):1835-40. PubMed ID: 7956289 [TBL] [Abstract][Full Text] [Related]
13. Overproduction of nitric oxide in cytokine-mediated and septic shock. Kilbourn RG; Griffith OW J Natl Cancer Inst; 1992 Jun; 84(11):827-31. PubMed ID: 1375655 [No Abstract] [Full Text] [Related]
14. Inhibition of NO synthesis in septic shock. Geroulanos S; Schilling J; Cakmakci M; Jung HH; Largiader F Lancet; 1992 Feb; 339(8790):435. PubMed ID: 1346701 [No Abstract] [Full Text] [Related]
15. Selective inhibition of the activity of inducible nitric oxide synthase in septic shock. Thiemermann C Prog Clin Biol Res; 1995; 392():383-92. PubMed ID: 8524946 [No Abstract] [Full Text] [Related]
16. Vascular biology: relevance of nitric oxide in vascular and nonvascular tissue with normal and decreased renal function. Blantz RC Blood Purif; 1994; 12(1):30-5. PubMed ID: 7527221 [TBL] [Abstract][Full Text] [Related]
17. Indirect evidence for stimulation of nitric oxide release by tumour necrosis factor-alpha in human veins in vivo. Simper D; Strobel WM; Linder L; Haefeli WE Cardiovasc Res; 1995 Dec; 30(6):960-4. PubMed ID: 8746212 [TBL] [Abstract][Full Text] [Related]